This study explored whether bacterial endotoxins, in the form of lipopolysaccharides (LPS), could have an injurious effect on the biliary tract in conjunction with ischemia. A total of 64 rats were randomly assigned to 4 groups: sham operation (sham group), 1 mg/kg LPS intraperitoneal (LPS group), hepatic ischemia/reperfusion (IR; IR group), and IR combined with LPS (IR1LPS group). Following 1 or 6 hours of reperfusion, serum liver tests, bile duct histology, immunofluorescence microscopy (zonula occludens-1 [ZO-1]), bile composition (bile salts, phospholipids, lactate dehydrogenase), hepatic gene expression (bile salt transporters and inflammatory mediators), as well as serum and biliary cytokine concentrations were quantified and compared between the study groups. In addition, the integrity of the blood biliary barrier (BBB) was assayed in vivo using horseradish peroxidase (HRP). LPS administration induced severe small bile duct injury following 6 hours of reperfusion. Furthermore, total bile salts and bilirubin concentrations in serum were increased in the LPS groups compared with sham controls (LPS, 1 3.3-fold and 11.9-fold; IR1LPS, 1 3.8-fold and 11.7-fold, respectively). The BBB was impaired in the LPS groups as evidenced by elevated levels of HRP in bile (14.9-fold), and decreased expression of claudin 1 (-6.7-fold) and claudin 3 (-3.6-fold). LPS was found to be a potent inducer of small bile duct injury following hepatic ischemia and 6 hours of reperfusion. This injury was associated with increased permeability of the BBB and impaired hepatic bile salt clearance.
In the current era of organ shortage, an increasing number of extended criteria donors are considered for transplantation, such as those from donation after circulatory death (DCD). Although short-term graft survival rates similar to that of recipients of organs from donation after brain death (DBD) have been reported, the use of these DCD livers has been hampered by the high incidence of ischemic-type biliary strictures (ITBSs). (1) Systemic endotoxemia has previously been reported to occur during both organ retrieval and implantation of the liver graft. (2, 3) Furthermore, the underlying cause of death frequently causes increased endotoxin levels in organ donors. (4) DCD organs in situ are exposed to a period of hypoperfusion and hypoxia prior to the start of cold perfusion. All of the intraabdominal organs become ischemic, including the gut, and this could potentially result in the release of endotoxins into the portal circulation which might then be flushed into the liver during cold perfusion. (5) Endotoxemia aggravates organ preservation injury and has been associated with increased mortality following transplantation in animal studies. (6, 7) It can substantially exacerbate hepatic IR injury because it aggravates the inflammatory response by activating liver-resident macrophages and by enhancement of leukocyte recruitment. (8) If endotoxemia is directly injurious to bile ducts, or augments the effects of ischemia, then potentially it might contribute to ITBS, and it would be relevant to determine the acute effect of endotoxin on the biliary tract.
The blood biliary barrier (BBB) is formed by tight junctions between cholangiocytes and keeps bile separated from the blood stream. (9) Several in vitro studies using cultured cholangiocytes have shown that the integrity of these tight junctions is affected by endotoxins, cytokines, and endoplasmic reticulum stress. (10, 11) Moreover, BBB dysfunction has been implicated in the pathophysiology of biliary stricture formation in multidrug resistance protein 2 (MDR2) -/-mice, an animal model for primary sclerosing cholangitis (PSC). (12) In MDR2 -/-mice, tight junction dysfunction was associated with leakage of bile in the portal tract area, with subsequent inflammation, periductal fibrosis, and stricture formation. Bile toxicity has already been implicated in the pathophysiology of ITBS, and disturbed tight junction architecture was observed in human common bile duct sections following cold preservation and reperfusion. (13, 14) However, the relationship between BBB dysfunction and biliary complications was not assessed in this human study.
The aim of the current study was to assess the effect of endotoxins, in the form of lipopolysaccharides (LPS) on the development of biliary injury in a model of warm hepatic-ischemia reperfusion.
Materials and Methods

ANIMALS
Male Sprague-Dawley rats weighing between 250 and 350 g were obtained from the Animal Resource Centre (Perth, Australia) and housed in a temperature-and light-controlled facility. The Animal Ethics Committee of the University of Queensland (MED/PAH/ 472/13/PAH) approved the study protocol in accordance with the Australian Code for the Care and Use of Animals for Scientific Purposes.
SURGICAL PROCEDURE AND EXPERIMENTAL GROUPS
A total of 64 animals were equally divided over 4 study groups: a sham group (sham) underwent midline laparotomy only; a LPS group (LPS) underwent midline laparotomy and intraperitoneal LPS administration; a hepatic IR group underwent 30 minutes of warm hepatic ischemia; and a combined group (IR1LPS) simultaneously received LPS into the peritoneal cavity and warm hepatic ischemia.
Briefly, laparotomy was performed under isoflurane anesthesia, and an atraumatic vascular clamp (BH030R, BBraun, Bethlehem, PA) was placed across the vasculobiliary pedicle of the median and left lateral lobe inducing ischemia to 70% of the liver avoiding splanchnic congestion (IR groups). Animals also received either vehicle (0.9% sterile NaCl) or 1 mg/kg LPS (dissolved in 0.9% NaCl) from Escherichia coli serotype 0111:B4 (L3012, Sigma-Aldrich, St. Louis, MO) into the peritoneal cavity. After 30 minutes of ischemia, the clamp was removed and the abdomen was closed. Administered LPS was not rinsed from the peritoneal cavity prior to closure of the abdomen.
Following 1 or 6 hours of reperfusion, relaparotomy was performed, and the common bile duct was cannulated to collect bile. Blood and tissue samples from the liver (ischemic and nonischemic lobes) and common bile duct were collected for further analysis.
BILE COMPOSITION ANALYSIS
After establishment of a steady bile flow during 10 minutes, 2 bile samples were collected. Lactate dehydrogenase (LDH) was measured via colorimetric assay (#5604-01, Bioo Scientific Corporation, Austin, TX). Phospholipids were measured spectrophotometrically using an enzymatic assay (433-36201, Wako, Osaka, Japan). For quantitative determination of bile salts, a Nexera X2 Ultra High Performance Liquid Chromatography system (Shimadzu, Kyoto, Japan) was used. Further details are provided in the Supporting Information. The individual bile salt concentrations were used to calculate the hydrophobicity index (HI). (15) 
ASSESSMENT OF BBB PERMEABILITY
The permeability of the BBB was assessed in vivo using a medium-sized protein, viz., horseradish peroxidase (HRP; P8250, Sigma-Aldrich, St. Louis, MO) as previously described by Takakuwa et al. (16) Sterile water containing 1000 U of HRP was injected in the inferior vena cava 30 minutes after bile duct cannulation. Bile was collected for a further 10 minutes, and HRP activity was assayed (Amplex red Assay kit, #A22188, Thermo Fisher Scientific, Waltham, MA).
BIOCHEMICAL ANALYSIS OF SERUM
Serum alanine transaminase (ALT), aspartate transaminase (AST), gamma-glutamyl transferase, alkaline phosphatase, and total bilirubin were measured using commercially available kits (Bioo Scientific Corporation, Austin, TX). Total bile salt concentration in serum was measured spectrophotometrically using a 3a hydroxysteroid dehydrogenase enzymatic assay (#80460, Crystal Chem, Inc., Chicago, IL).
ASSESSMENT OF SMALL AND LARGE BILE DUCT INJURY
Hilar and peripheral liver tissue as well as common bile duct were paraffin-embedded, and 4-lm thick sections were cut and stained with hematoxylin-eosin. Small and large intrahepatic bile ducts were identified based on their size (small 15-lm diameter, large > 15-lm diameter), (17) and semiquantitative bile duct injury scoring was performed. The Small Bile Duct Injury Severity Score encompassed 2 components: bile duct disruption (adopted from the Banff criteria for acute rejection (18) and ductular proliferation as previously described by Cheng et al. (19) Both items were scored using the following grades: 0, absent; 1, mild; 2, moderate; and 3, severe. The Large Bile Duct Injury Severity Score comprised 3 components: ductal disruption and the intraepithelial and hilar infiltration of inflammatory cells. These components were scored using the same grading from 0 to 3 as the small bile ducts. Two independent expert pathologists (M.G., C.M.C.) who were unaware of group assignments performed the scoring.
IMMUNOFLUORESCENT STAINING OF TIGHT JUNCTIONS
Hepatic cryosections (4-lm thick) were incubated with polyclonal rabbit anti-ZO-1 (1:100, 61-7300 Thermo Fisher Scientific, Waltham, MA) and mouse anticytokeratin (CK) 19 (1:100, NCL-CK19, Novocastra) overnight. A donkey anti-rabbit immunoglobulin G (IgG) and donkey anti-mouse IgG were used as secondary antibodies (1:2000, A21207 and A21202, Thermo Fisher Scientific, Waltham, MA); 4 0 ,6-diamidino-2-phenylindole (DAPI; D9542 Sigma-Aldrich, St. Louis, MO) staining was performed using a 1:500 dilution in 5% donkey serum and 2% bovine serum albumin.
RNA EXTRACTION AND REAL-TIME QUANTITATIVE POLYMERASE CHAIN REACTION
Total RNA was extracted from ischemic and nonischemic liver lobes and reverse transcribed into complementary DNA as previously described. (20) Real-time quantitative polymerase chain reaction (RTqPCR) was performed using the ViiA 7 real-time polymerase chain reaction machine (Invitrogen, Carlsbad, CA), and gene expressions were normalized to the geometric mean expression of 3 reference genes: glyceraldehyde 3-phosphate dehydrogenase, b 2 -microglobulin, and basic transcription factor 3. Primer sequences can be found in Supporting Table 1 .
CYTOKINE ARRAY
The concentrations of intercellular cell adhesion molecule 1 (ICAM1), interferon c, interleukin (IL) 1b, IL10, IL6, leptin, L-selectin, monocyte chemoattractant protein 1 (MCP1), tissue inhibitor metalloproteinase 1 (TIMP1), and tumor necrosis factor a (TNF-a) were assessed using a Quantibody multiplex enzyme-linked immunosorbent assay array (RayBiotech, Norcross, GA). The array was performed according to the manufacturer's instructions on serum (1:2 dilution) and bile (1:4 dilution) samples. The fluorescence intensity was quantified and data were analyzed using the Q-analyzer (RayBiotech, Norcross, GA).
STATISTICAL ANALYSIS
In each group, 8 animals were studied unless stated otherwise. Nonparametric tests were used to evaluate differences between groups, and data are reported as median (interquartile range [IQR]). A Kruskal-Wallis test with Dunn's correction for multiple comparisons was performed to compare intervention groups. For categorical data such as histological scoring, a Fisher's exact test was performed. A cutoff P value of 0.05 was used to determine significance. The statistical analysis was performed using GraphPad Prism 7 software (GraphPad, San Diego, CA).
Results
IR BUT NOT LPS INDUCES SIGNIFICANT HEPATOCELLULAR INJURY
The intraperitoneal administration of 1 mg/kg LPS alone had no effect on serum ALT compared with sham-operated animals with a median value of 35.5 U/ L (IQR, 31.1-40.3 U/L) after 1 hour and 50.9 U/L (IQR, 43.7-56.9 U/L) after 6 hours of reperfusion, respectively (P > 0.99 for both time points; Fig. 1 ). Liver IR, however, did induce hepatocellular injury as evidenced by increased serum ALT levels in the IR group at both time points (1 hour, 1 3.1-fold, P 5 0.007; 6 hours, 1 1.9-fold, P 5 0.046). There was no additional effect of LPS on serum ALT in the ischemic group at either time point. This observation was further supported by serum AST elevation in the ischemic groups at the 6-hour time point (Supporting Table 2 ).
LPS AND NOT IR INDUCES SIGNIFICANT SMALL BILE DUCT INJURY FOLLOWING 6 HOURS OF REPERFUSION
The intrahepatic large bile ducts, including the peribiliary plexus, as well as the common bile duct showed no histological signs of injury in any of the study groups (Supporting Table 3 ). In contrast, small bile ducts were affected and representative images of each group are shown in Fig. 2A . Severe small bile duct injury (score-4) occurred in none of the sham animals and only in a single animal in the IR group (14%). LPS administration on the other hand caused severe biliary injury in 5 (63%) animals in both the LPS and IR1LPS group (P 5 0.004). In addition to the histological scoring, LDH leakage into bile was measured as a biomarker for biliary injury. Only data from the 6-hour time point will be presented below. All results from the 1-hour time point can be found in the Supporting Information.
FIG. 1.
Ischemia-reperfusion results in hepatocellular injury following 1 and 6 hours of reperfusion. Serum ALT (U/L) was determined in groups of rats (n 5 7-8) that were sham-operated, exposed to 1 mg/kg LPS or 70% hepatic inflow obstruction during 30 minutes (IR), or a combination of the latter 2 (IR1LPS) followed by reperfusion for 1 and 6 hours. Data are depicted as box and whisker plots showing median, minimum, and maximum values. Statistical significance was tested using a Kruskal-Wallis test with Dunn's correction for multiple comparisons. *P < 0.05; **P < 0.01; ***P < 0.001.
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LPS IMPAIRS HANDLING OF BILIARY CONSTITUENTS FOLLOWING 6 HOURS OF REPERFUSION
Bile flow was not significantly different between the intervention groups (Fig. 3A) . LPS administration, with or without IR, did result in a significant increase in the serum bile salt concentration. The mean concentration of total bile salt in serum was 45. /Taurocholate cotransporting polypeptide (NTCP) was reduced ( Fig. 3C ; P 5 0.02 and P 5 0.04, respectively). Furthermore, LPS administration led to a significant increase in serum bilirubin (Fig. 3D) . The bilirubin concentration in the LPS and IR1LPS was 2.1 mg/dL (IQR, 1.9-2.5 mg/dL) and 1.9 mg/dL (IQR, 1.7-2.4 mg/dL) compared with 1.1 mg/dL (IQR, 1.0-1.3 mg/dL) and 1.1 mg/dL (IQR, 1.0-1.5 mg/dL) in the sham and IR groups, respectively. This was accompanied by a reduction in messenger RNA (mRNA) expression of multidrug resistance-associated protein 2 (MRP2), the adenosine triphosphate-binding cassette protein responsible for secretion of glucuronidated bilirubin into the bile canaliculi, in the LPS group (Supporting Fig. 2 ). Note that, gene expression levels of the nonischemic lobes will not be discussed in this manuscript but can be found in the Supporting Figs. 3 and 4.
LPS INCREASED THE PERMEABILITY OF THE BBB FOLLOWING 6 HOURS OF REPERFUSION
BBB permeability was measured in vivo using HRP to investigate whether the development of biliary injury in our model was accompanied by BBB dysfunction. IR did not cause an increase in biliary HRP above the background levels observed in the controls, indicating an intact barrier (Fig. 4A) . In the LPS group, however, the BBB was impaired as evidenced by significant leakage of HRP from blood to bile (14.9-fold; P < 0.001), with a trend apparent in the IR1LPS group (13.7-fold; P 5 0.06). At the transcriptional level, the expression of tight junction proteins, claudin 1 and claudin 3, was markedly lower in the LPS and IR1LPS group compared with the sham and IR groups (Fig. 4B,C) . Conversely, expression of tight junction protein zonula occludens-1 (ZO-1) was 2-fold and 1.8-fold higher in the LPS and IR1LPS group compared with sham-operated animals (P 5 0.005 and 0.002, respectively; Fig. 4D ).
Immunofluorescence costaining for CK 19 and ZO-1 showed that ZO-1 was present at the junctions of neighboring cholangiocytes in animals that did not develop biliary injury (Fig. 5A-D) . Animals that developed biliary injury, such as those in the IR1LPS group, showed markedly altered tight junction morphology with an irregular ZO-1 staining pattern not confined to junctions of neighboring cholangiocytes (Fig. 5E-H) .
BILE COMPOSITION FOLLOWING 6 HOURS OF REPERFUSION WAS NOT TOXIC
There were no changes in total bile salt output following LPS administration in the IR1LPS group ( . At the transcriptional level, the expression of the bile salt export pump (BSEP) was not affected in the intervention groups, whereas the expression of the canalicular phospholipid flippase (MDR2) was reduced following LPS administration (Supporting Fig. 2 ). Taken together, the biliary bile salt/phospholipid ratio was unaltered as both parameters were affected in a similar fashion (Fig. 6C) . Although the biliary bile salt/phospholipid ratio did not change across the intervention groups, we assessed whether the biliary bile salt pool itself was more hydrophobic and therefore potentially more toxic. Analysis of biliary bile salt composition revealed that glycine and taurine conjugates of cholic acid were most abundant in all groups (Supporting Table 4 ). The HI of the biliary bile salt pool was calculated as a surrogate measure of pool toxicity (Fig. 6D ). LPS induced a significant reduction in the HI, suggesting a more hydrophilic and less toxic composition of the biliary bile salt pool (P 5 0.02). Expression levels of genes coding for key enzymes of both the classical (eg, cytochrome P450 [CYP] 7A1]) and alternative (eg, CYP7B1) bile salt synthesis pathways were assessed (Fig. 7) . LPS induced a shift from the classical pathway to the alternative (or acidic) bile salt synthesis pathway. In the LPS group, gene expression of CYP7A1 was 5.8-fold lower compared with sham animals (P 5 0.005; Fig. 7A ), whereas CYP7B1 and CYP27A1 expression were 6.4-and 2.6-fold higher, respectively (P 5 0.001 and P 5 0.02; Fig. 7B,C) . A similar pattern was seen in the IR1LPS groups (CYP7B1 1 10-fold, CYP27A1 1 2.9-fold; P < 0.001 and P 5 0.003, respectively). CYP8B1, coding for sterol 12 a-hydroxylase, an enzyme determining the hydrophilicity/hydrophobicity balance of newly   FIG. 4 . Increased permeability of the BBB following 6 hours of reperfusion. Groups of rats (n 5 7-8) were sham-operated, exposed to LPS or 70% hepatic inflow obstruction during 30 minutes (IR), or a combination of the latter 2 (IR1LPS) followed by reperfusion for 6 hours. HRP output in (A) bile following intravenous injection of 1000 IU HRP and hepatic expression of genes encoding tight junction proteins (B) claudin 1, (C) claudin 3, and (D) ZO-1 was determined. Data are depicted as box and whisker plots showing median, minimum, and maximum values. Statistical significance was tested using a Kruskal-Wallis test with Dunn's correction for multiple comparisons. *P < 0.05; **P < 0.01; ***P < 0.001.
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synthesized bile salts, was significantly lower in the LPS groups (6.7-fold and 7.8-fold; P 5 0.02 and P 5 0.003; Fig. 7D , respectively).
INDUCTION OF INFLAMMATORY RESPONSE FOLLOWING 6 HOURS OF REPERFUSION
To determine the inflammatory response of the liver and bile ducts to LPS administration, cytokines in liver tissue, serum, and bile were examined (Fig. 8,  Supporting Fig. 5 ). Following IP administration of LPS, serum concentrations of ICAM1, TNF-a, and MCP1 were significantly increased. Serum IL6 levels were not significantly different between groups. In the liver, IR did not induce an inflammatory response, whereas in the LPS groups (LPS and IR1LPS) IL6, ICAM1, TNF-a, and MCP1 gene expression was significantly higher compared with the sham and IR groups. As cholangiocytes themselves are capable of producing cytokines such as MCP1, IL6, and TNF-a, their levels in bile were analyzed. Biliary MCP1 concentrations were significantly higher in the LPS and IR1LPS groups compared with sham (LPS 1 8.3-fold, IR1LPS 1 10.3-fold; P 5 0.03 and P < 0.001, respectively). Biliary ICAM1 and IL6 showed an inverse pattern compared with serum and mRNA expression levels with significantly decreased concentrations in the LPS and LPS1IR group. It, however, needs to be noted that IL6 levels were overall very low in bile. The concentrations of TIMP1 protein in bile was found to be significantly increased in the LPS groups, matching hepatic gene expression levels (Supporting Fig. 5 ).
Discussion
The present study demonstrates that endotoxins, in the form of intraperitoneal administered LPS, are capable of inducing small bile duct injury within 6 hours of exposure in rats. This occurred independently of hepatocellular injury. LPS administration, furthermore, disturbed the function of the BBB and impaired bile salt clearance in the groups that developed biliary injury.
In the current study, no evidence of biliary injury was found in the IR group following 6 hours of reperfusion, although increased levels of ALT were observed at that time point. This is in conflict with existing literature reporting that cholangiocytes are more vulnerable to reperfusion injury than hepatocytes. (22) Furthermore, prolonged warm ischemia is a known risk factor for the development of ITBS. (13) The hepatocellular injury in the current study, however, might have been transient as the serum half-life of ALT is 4.5 to 8.0 hours. (23) This was further supported by the decrease in serum ALT levels between the 1-and 6-hour time point. Using a longer duration of ischemia for this experiment may have resulted in biliary injury, but the clamp time used was chosen to align with clinical DCD organ procurement.
(1) However, rats respond differently to IR injury than humans as they do not display any evidence of biliary injury on histology following exposure to 30 minutes of warm and 3 hours of cold ischemia (24) and in future experiments, varying clamp times may need to be included.
Because endotoxic shock can be a result of systemic exposure to LPS, it might be argued that the biliary damage seen in the LPS-treated groups is the result of ischemic biliary injury due to hypotension, (25) although we intended to explore a direct effect of LPS on cholangiocytes. For this reason, the dose of endotoxin used in our experiments was an order of magnitude lower Groups of rats (n 5 7-8) were sham-operated, exposed to LPS or 70% hepatic inflow obstruction during 30 minutes (IR), or a combination of the latter 2 (IR1LPS) followed by reperfusion for 6 hours. Data are depicted as box and whisker plots showing median, minimum, and maximum values. Statistical significance was tested using a Kruskal-Wallis test with Dunn's correction for multiple comparisons. *P < 0.05; **P < 0.01. than the commonly used intraperitoneal dose of 10-30 mg/kg that induces shock. (25) Caraceni et al. (8) have shown previously that 1 mg/kg LPS alone did not induce a significant drop in systolic blood pressure or liver perfusion. It was also considered that a lower dose might be more clinically relevant.
In the present study, HRP was used to assess the permeability of the BBB in vivo. HRP appears in bile via 2 distinct routes, transcellular and paracellular, the latter being the fastest across tight junctions. (26) More HRP appeared in bile in the LPS groups suggesting a loss of function of the tight junction barrier. This was further supported by almost undetectable expression of claudin 1 and claudin 3, 2 important components of tight junctions. ZO-1 staining showed marked disruption of tight junction morphology with an irregular staining pattern in animals that developed severe biliary injury. Endotoxins were found to disrupt tight junctions in cell culture experiments. (10) However, to the best of our knowledge, the present study is the first report of BBB disruption in an animal model of endotoxemia.
When the BBB is impaired, bile can leak back into the portal area resulting in clinical signs of cholestasis. (27) Even though bile flow was not significantly impaired in this model, LPS was found to increase the circulating levels of bilirubin and bile salts and to lower the hepatic expression of NTCP and MRP2. The impaired tight junction function could be an explanation for elevated serum bile salts. Alternatively, the latter may be due to LPS-mediated repression of bile salt uptake via NTCP. (28) This study did not reveal an alteration in biliary bile salt/phospholipid ratio or an increased proportion of hydrophobic/toxic bile acids. This could partially be explained by the use of rats in our experiments because FIG. 7 . Hepatic expression of genes engaged in bile salt synthesis. mRNA levels of (A) CYP7A1, (B) CYP7B1, (C) CYP27A1, and (D) CYP8B1 were determined by RT-qPCR. Median and left lateral liver segments were assessed in rats (n 5 7-8 per group) that were sham-operated, exposed to LPS or 70% hepatic inflow obstruction during 30 minutes (IR), or a combination of the latter 2 (IR1LPS) followed by reperfusion for 6 hours. Data are depicted using box and whisker plots showing median, minimum, and maximum values. Statistical significance was tested using a Kruskal-Wallis test with Dunn's correction for multiple comparisons. *P < 0.05; **P < 0.01; ***P < 0.001.
FIG. 8.
Hepatic expression of genes related to inflammation, and cytokine concentrations in serum and bile. Hepatic mRNA expression of IL6, ICAM1, TNF-a, and MCP1 in the median and left lateral liver segments was assessed using RT-qPCR. Cytokine concentrations of IL6, ICAM1, TNF-a, and MCP1 in serum and bile (pg/mL). Groups of rats (n 5 7-8) were sham-operated, exposed to LPS or 70% hepatic inflow obstruction during 30 minutes (IR), or a combination of the latter 2 (IR1LPS) followed by reperfusion for 6 hours. Data are depicted using box and whisker plots showing median, minimum, and maximum values. Statistical significance was tested using a Kruskal-Wallis test with Dunn's correction for multiple comparisons. *P < 0.05; **P < 0.01; ***P < 0.001.
they have less toxic bile compared with humans. (15) Additionally, our injury model was not extreme, with a short duration of IR, a low dose of LPS, and a short follow-up duration. The exact mechanisms by which LPS induces biliary injury in our model remain to be determined. Kupffer cells have previously been shown to play a pivotal role in the development of LPS-enhanced preservation injury and endotoxemia-induced cholestasis, as their depletion from the liver was found to reduce the injury. (7, 28) Cholangiocytes themselves, however, also participate in the innate and adaptive immune response. They express toll-like receptor (TLR) 4, and they produce cytokines such as IL6 and TNF-a in response to LPS. (29) This TLR-mediated immune response not only aids in the defense against pathogens, but it has also been implicated in the pathophysiology of PSC, primary biliary cholangitis, and cystic fibrosis-associated cholangiopathies. (29) (30) (31) (32) In the present study, cytokines were detected in bile, and their levels were altered by LPS administration. This suggests that the local inflammatory milieu contributes to the development of biliary injury.
Previous studies have linked immunological factors with the development of ITBS, especially when occurring in the periphery of the liver. (13, 33) Furthermore, a study by Friedrich et al. (34) identified that CD14/ TLR4 signaling, a critical element in the innate immune response to factors such as LPS, played a pivotal role in ITBS formation. In the current study, we found that, after 6 hours of reperfusion, the biliary MCP1 protein concentration was significantly increased upon LPS administration, and this chemokine has previously been linked to myofibroblastic transformation and differentiation of portal myofibroblasts. (35) In addition, the concentrations of TIMP1 protein in bile and hepatic gene expression were significantly elevated in the LPS groups, which could suggest the initiation of a fibrotic response. (36) As with any experimental animal study, though, there are potential design limitations that could affect the interpretation of results and a single set of experiments cannot address all the relevant questions. The difficulty of replicating human ischemic injury conditions in rodents has been alluded to above, as has the choice of endotoxin dose. In the present study, only short-term effects were examined, and a more complex study will be needed to determine the occurrence of stricture formation over time.
This study has indicated that endotoxins, even at a low concentration of 1 mg/kg, are potent inducers of biliary injury. It might be the case that DCD organ procurement exposes donor livers to higher levels of endotoxins compared with DBD donors due to the period of shock prior to the start of cold perfusion, although human data supporting this is lacking. (37) Our studies, albeit only using a short duration experimental protocol, indicate that it may be worthwhile exploring endotoxin exposure during human organ retrieval and its effect on the development of ITBS. If endotoxin is implicated in ITBSs, then it might be possible to limit endotoxin exposure during organ procurement by ligating or venting the portal vein (PV).
